沙特阿拉伯王国政府所属的官方政府网站。
沙特官方政府网站的域名以下列后缀结尾 gov.sa
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
在数字政府管理局注册,编号:
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
Ensure the website is using the HTTPS protocol.
在数字政府管理局注册,编号:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Durvalumab | Imfinzi | 4.8. Undesirable effects | Nov,2022 |
| Dabigatran Etexilate Mesylate | Pradaxa | 4.8. Undesirable effects | May,2024 |
| Phenytoin | Accofil | 4.4 Special Warnings and Special Precautions for Use | May,2024 |
| Bemiparin Sodium | Hibor | 4.3 Contraindications | Mar,2023 |
| Zanubrutinib | Brukinsa | 2.3 Dosage Modifications for Drug Interactions | Mar,2023 |
| Furosemide | Lasix | 4.4 Special Warnings and Special Precautions for Use | Mar,2023 |
| Lansoprazole | Takepron | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Mar,2023 |
| Colistimethate Sodium | Colistin | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Mar,2023 |
| Bosutinib | Bosulif | 4.8 Undesirable effects | Mar,2023 |
| Acetylsalicylic Acid | Aspirin® Protect | Drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms | Mar,2023 |
最后更新日期: 13/08/2026 at 02:25 下午 Saudi Arabia time
此页面尚未收到任何反馈。
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。